Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells

European Journal of Histochemistry

Volumn 54, Issue 1, 2010, Pages 14-17

  Nemolato, S ^a   Cabras, T ^a   Fanari, M U ^a   Cau, F ^a   Fraschini, M ^a   Manconi, B ^a   Messana, I ^a   Castagnola, M ^a,b   Faa, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

Author keywords

Chymase; Mast cells; Thymosin 4; Tryptase

Indexed keywords

EID: 77749236972     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2010.e3     Document Type: Article

References (30)

1. Rao KN, Brown MA. Mast cells. Multifaceted immune cells with diverse roles in health and disease. Ann N.Y. Acad Sci 2008;1143:83-104.
2. Kitamura Y, Kasugai T, Arizono N, Matsuda H. Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci 1993;306:185-91.
3. Barret K, Pearce F. Heterogeneity of mast cells. In: Uvnas B, ed. Histamine and histamine antagonist, Springer-Verlag, Berlin 991, pp. 93-116.
4. Razin E, Ihle JN, Seldin D et al. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains condroitin sulfate E proteoglycan. J Immunol 1984;132:1479-86.
5. Tsai M, Takeishi T, Thompson H et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat ckit ligand, stem cell factor. Proc Natl Acad Sci 1991;88:6382-86.
6. Barret K, Szucs E, Metcalfe D. Mast cells heterogeneity in higher animals: a comparison of the properties of autologous lung and intestinal mast cell from nonhuman primates. J Immunol 1986;137:2001-8.
7. Befus D, Goodacre R, Dyck N, Bienenstock J. Mast cell heterogeneity in man. I. Histologic studies of the intestine. Int Arch Allergy Appl Immunol 1985;76: 232-36.
8. Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981;256:11939-43.
9. Schechter NM, Choi JK, Slavin DA et al. Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol 1986;137:962-70.
10. Caughey GH. New developments in the genetics and activation of mast cell proteases. Mol Immunol 2002;38:1353-7.
11. Beaven MA. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 2009;39:11-25.
12. Edwards ST, Cruz AC, Donnelly S, et al. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J Pathol 2005; 206:279-90.
13. Pearce A. Histochemistry 2th ed. J&A Churchill Ltd, 1960.
14. Csaba G. Alcian blue-safranin method for mast cells. In: JD Bancroft and Steven A eds. Theory and practice of histological techniques. Livingstone, New York, 1990, p 639.
15. Vodenicharov A, Leiser R, Gulubova M, Vlaykova T. Morphological and immunocytochemical investigations on mast cells in porcine ureter. Anat Histol Embryol 2005;34:343-49.
16. Frangogiannis N, Burns A, Michael L, Entman M. Histochemical and morphological characteristics of canine cardiac mast cells. Histochem J 1999; 31:221-9.
17. Chen C, Li M, Yang H et al. Role of thymosins in cancer and other organ systems. World J Surg 2005;29:264-70.
18. Huff T, Muller CSG, Otto AM et al. Betathymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 2001;33:205-20.
19. Cha HJ, Jeong KJ, Kleinman HK . Role ofthymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 2003;95: 1674-80.
20. Kobayashi T, Okada F, Fujii N et al. Thymosin beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 2002;160:869-82.
21. Wang WS, Chen PM, Hsiao HL, Ju SY. Overexpression of the thymosin beta4 gene is associated with malignant progression of SW480 cancer cells. Oncogene 2003;22:3297-306.
22. Ji P, Diederichs S, Wang W et al. MALAT-1 a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003;22:6087-97.
23. Wang WS, Chen PM, Hsiao HL et al. Overexpression of the thymosin beta4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 2004;23:6666-71.
24. Larsson LI, Holck S. Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum Pathol 2007;38:114-9.
25. Reti R, Kwon E, Qiu P et al. Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur J Oral Sci 2008;116:424-30.
26. Sosne G, Chan CC, Thai K et al. Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators invivo. Exp Eye Res 2002;74:293-9.
27. Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 1997;11:474-81.
28. Grant DS, Rose W, Yaen C et al. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 1999;3:125-35.
29. Smart N, Rossdeutsch A, Rile PR. Thymosin Beta4 and angiogenesis: modes of action and therapeutic potential. Angiogenesis 2007;10:229-41.
30. Goldstein AL. Thymosin beta4: a new molecular target for antitumor strategies. J Natl Cancer Inst 2003;95:1646-7.